Is sertraline treatment or depression remission in depressed Alzheimer’s patients associated with improved caregiver wellbeing? The Depression in Alzheimer’s Disease Study 2 (DIADS-2)

OBJECTIVES: To assess if sertraline treatment (vs. placebo) or remission of depression at 12 weeks (vs. non-remission) in Alzheimer’s patients is associated with improved caregiver wellbeing. DESIGN: A randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of sertrali...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Longmire, Crystal V. Flynn, Drye, Lea T., Frangakis, Constantine E., Martin, Barbara K., Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Weintraub, Daniel, Lyketsos, Constantine G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910508/
https://ncbi.nlm.nih.gov/pubmed/24314887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2013.02.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados